Novo Nordisk is now second biggest firm in Europe after study finds that Wegovy cuts risk of heart attacks

Novo Nordisk’s obesity medicine Wegovy reduces the risk of heart attacks and strokes according to a highly anticipated study. People with obesity or are overweight with a history of heart …

Novo Nordisk is now second biggest firm in Europe after study finds that Wegovy cuts risk of heart attacks Read More

Novo Nordisk invests $2.3 bln to new production facility for producing chronic diseases curing products

The Danish drugmaker, Novo Nordisk, announced that it will invest 15.9 billion Danish crowns ($2.29 billion) to expand a new production facility in Denmark for producing chronic diseases curing products …

Novo Nordisk invests $2.3 bln to new production facility for producing chronic diseases curing products Read More